“LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.”
Sas-Chen, A., M. R. Aure, L. Leibovich, S. Carvalho, Y. Enuka, C. Korner, M. Polycarpou-Schwarz, S. Lavi, N. Nevo, Y. Kuznetsov, J. Yuan, F. Azuaje, F. A. M. G. C. K. K. Oslo Breast Cancer Research Consortium SauerTorillGeislerJurgenHofvindSolveigBathenTone, I. Ulitsky, S. Diederichs, S. Wiemann, Z. Yakhini, V. N. Kristensen, A. L. Borresen-Dale and Y. YardenEMBO Mol Med, 2016.